Roy Jeremy W, Taylor Catherine A, Ouellette Rodney J, Lewis Stephen M
Atlantic Cancer Research Institute, Hôtel-Dieu Pavilion, Moncton, NB, Canada.
Beatrice Hunter Cancer Research Institute, Halifax, NS, Canada.
Methods Mol Biol. 2022;2508:341-352. doi: 10.1007/978-1-0716-2376-3_22.
Extracellular vesicles (EVs) are membrane-bound nanoparticles that carry DNA, RNA, and protein cargoes and are found in a variety of biofluids. EVs, along with cell-free DNA (cfDNA), have attracted interest as a source of biomarker material for liquid biopsy, a process in which a sample of body fluid is used for the detection or monitoring of disease. The Vn96 synthetic peptide facilitates the isolation of both EVs and cfDNA from multiple body fluids, including human plasma, placing it as a versatile tool for the capture of multiple biomarker materials for disease detection and/or treatment monitoring. In this chapter, we describe an optimized protocol for Vn96-mediated isolation of EVs and cfDNA from human plasma samples, as well as downstream methods for EV enumeration and DNA, RNA, and protein extraction from the material captured by Vn96 for use in biomarker discovery or detection.
细胞外囊泡(EVs)是携带DNA、RNA和蛋白质货物的膜结合纳米颗粒,存在于多种生物流体中。EVs与游离DNA(cfDNA)一起,作为液体活检的生物标志物材料来源引起了人们的兴趣,液体活检是一种利用体液样本进行疾病检测或监测的过程。Vn96合成肽有助于从包括人血浆在内的多种体液中分离EVs和cfDNA,使其成为用于捕获多种生物标志物材料以进行疾病检测和/或治疗监测的通用工具。在本章中,我们描述了一种优化的方案,用于从人血浆样本中通过Vn96介导分离EVs和cfDNA,以及用于EV计数和从Vn96捕获的材料中提取DNA、RNA和蛋白质的下游方法,以用于生物标志物发现或检测。